These Two Companies Just Announced a Partnership to Develop Multiple Gene Therapies
EliasSch / Pixabay

These Two Companies Just Announced a Partnership to Develop Multiple Gene Therapies

According to a story from BioSpace, the gene therapy companies Sarepta Therapeutics, Inc. and StrideBio, Inc. have recently announced the completion of a licensing and collaboration agreement that could lead…

Continue Reading These Two Companies Just Announced a Partnership to Develop Multiple Gene Therapies

New Technology for Diagnosing Rare Conditions by Photograph May Foster Employment Discrimination?

As discussed in a recent article on PatientWorthy the FDNA has recently developed a new kind of algorithm which can diagnose rare genetic conditions such as Angelman syndrome, Williams syndrome, and Fragile X syndrome using…

Continue Reading New Technology for Diagnosing Rare Conditions by Photograph May Foster Employment Discrimination?
Angelman Syndrome Clinic Network is Now International
https://pixabay.com/en/hands-world-map-global-earth-600497/

Angelman Syndrome Clinic Network is Now International

Angelman Syndrome (AS) is a neurogenetic disorder. It's not fatal, but prevents patients' from living independently. It causes neurological impairment, seizures, and balance issues among other problems. It's caused by a…

Continue Reading Angelman Syndrome Clinic Network is Now International

A Recent Study Has Found That Minocycline Doesn’t Benefit People with Angelman Syndrome

The drug minocycline is a tetracycline antibiotic. Previous research using mouse models has indicated that it may have anti-inflammatory and antiapoptotic (prevents cell death) properties and may benefit some neurological…

Continue Reading A Recent Study Has Found That Minocycline Doesn’t Benefit People with Angelman Syndrome
Angelman Syndrome Treatment Being Developed is Awarded ‘Orphan Drug’ Status in the U.S.
Source: Pixabay

Angelman Syndrome Treatment Being Developed is Awarded ‘Orphan Drug’ Status in the U.S.

A new drug being developed to treat Angelman syndrome (AS) has just been approved for ‘orphan drug’ status in the U.S., reports GlobeNewswire. The drug, called GTX-101, works by activating the…

Continue Reading Angelman Syndrome Treatment Being Developed is Awarded ‘Orphan Drug’ Status in the U.S.
An Experimental Treatment for Fragile X and Angelman Syndromes Gets Fast Track Designation
Source: Pixabay

An Experimental Treatment for Fragile X and Angelman Syndromes Gets Fast Track Designation

According to a story from pharmiweb.com, the pharmaceutical company Ovid Therapeutics announced recently that the U.S. Food and Drug Administration (FDA) has given its drug candidate OV101 Fast Track designation…

Continue Reading An Experimental Treatment for Fragile X and Angelman Syndromes Gets Fast Track Designation
Photographer Captures Daily Life of Rare Families with Dignity and Grace
Pexels / Pixabay

Photographer Captures Daily Life of Rare Families with Dignity and Grace

Rare disease began shaping acclaimed photographer, Karen Haberberg's family years before she was born. Her parents had given birth to her older brother, who was diagnosed with Tay-Sachs. Tay-Sachs is a…

Continue Reading Photographer Captures Daily Life of Rare Families with Dignity and Grace